Cargando…

IL-8 is a novel marker for breast cancer

Detalles Bibliográficos
Autores principales:	Chavey, C, Freund, A, Durand, S, Lazennec, G
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2005
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4233562/ http://dx.doi.org/10.1186/bcr1141

Ejemplares similares

Measurement of granulocyte colony-stimulating factor and IL-6, IL-8 and IL-10 as an early predictor for septic patients
por: Razek, A Abdel, et al.
Publicado: (2005)

Immune gene signatures and tumor intrinsic markers delineate novel immunogenic subtypes of breast cancer
por: Miller, Lance D, et al.
Publicado: (2014)

P62. Effectiveness of melatonin, IL-25 and siRNA IL-17B in growth control of breast cancer cell lines
por: Bottaro Gelaleti, G, et al.
Publicado: (2014)

Time course of granulocyte–macrophage colony-stimulating factor and IL-8 in severe sepsis: are the initial low levels of IL-8 a consequence of immunodepression?
por: Mera, Simona, et al.
Publicado: (2007)

Oestrogen receptor negative breast cancers exhibit high cytokine content
por: Chavey, Carine, et al.
Publicado: (2007)

Multicentre study of CASP8 polymorphisms in breast cancer
por: Shephard, N, et al.
Publicado: (2008)

IL-12 primed CD8+ T-cells possess enhanced persistence and anti-tumor efficacy because of greater IL-7 responsiveness
por: Johnson, C Bryce, et al.
Publicado: (2013)

Procalcitonin, IL-10 and sCD25 as diagnostic and prognostic markers in critically ill patients
por: Focà, A, et al.
Publicado: (2012)

Association of MMP8 gene variation with breast cancer prognosis
por: Decock, J, et al.
Publicado: (2008)

Accumulation of MDSC subsets in renal cell carcinoma correlates with grade and progression free survival, and is associated with intratumoral expression of IL-1β, IL-8 and CXCL5
por: Najjar, Yana G, et al.
Publicado: (2014)

Expression analysis of novel biomarkers for breast cancer
por: Laversin, SA, et al.
Publicado: (2008)

Lack of correlation between markers of breast cancer initiating cells
por: Liu, Y, et al.
Publicado: (2010)

Assessing the functional role of caspase-8 gene variants in breast cancer
por: Rigas, SH, et al.
Publicado: (2010)

Novel antitumor mechanism-of-action of an IL-2 fusion protein mediated by tumor associated macrophage repolarization and innate-like CD8+ memory T cells
por: Xu, Wenxin, et al.
Publicado: (2014)

IL-33: a novel cytokine with proinflammatory properties
por: Palmer, Gaby, et al.
Publicado: (2007)

IL-5, IL-8 and tgf-beta expressions in chronic rhinosinusitis patients with nasal polyps and their correlation to tissue's cellularity and disease relapsing
por: Anselmo-Lima, Wilma T, et al.
Publicado: (2013)

A critical need for molecular markers of breast cancer risk and risk reduction
por: Johnson, KA, et al.
Publicado: (2005)

Role of CASP8 D302H and other apoptosis gene variants in breast cancer
por: Mistry, SH, et al.
Publicado: (2006)

Selective costimulation by IL-15R/IL-15, but not IL-2R/IL-2, allows the induction of high numbers of tumor-specific CD8+ T cells by human dendritic cells matured in conditions of acute inflammation
por: Hansen, Morten, et al.
Publicado: (2015)

IL-10 plasma and bronchoalveolar lavage levels used as markers of candida bronchopneumonia during fungal sepsis
por: Giarratano, A, et al.
Publicado: (2004)

CITN11-02 interim trial results: subcutaneous administration of recombinant human IL-15 (rhIL-15) is associated with expansion of peripheral blood CD56+ NK cells and CD8+ T cells
por: Morishima, Chihiro, et al.
Publicado: (2015)

BCL2 is a predictive marker of adjuvant CMF regimen in triple-negative breast cancer patients
por: Bouchalova, K, et al.
Publicado: (2011)

Proteomic analysis of Systemic Sclerosis serum identifies the toll-like receptor agonists S100A8/A9 as a novel possible pathogenic marker
por: van Bon, L, et al.
Publicado: (2010)

Turkish DIRA patient with novel IL1RN gene mutation
por: Berdeli, A, et al.
Publicado: (2015)

A high IL6/IL17 ratio combined with low IL5 expression is correlated with poor survival in squamous cervical cancer
por: Punt, Simone, et al.
Publicado: (2014)

Pancreatic stone protein as a novel marker for neonatal sepsis
por: Schlapbach, L, et al.
Publicado: (2012)

Gene expression profiles and the TP53 mutation status are powerful prognostic markers of breast cancer
por: Langerød, A, et al.
Publicado: (2005)

Effects of 8 weeks of Stealth(® )supplementation on body composition, muscle strength and mass, markers of satellite cell activation, and clinical safety markers in males
por: Spillane, Micheil B, et al.
Publicado: (2015)

Linking tumor with systemic environment in the search for novel biomarkers in breast cancer
por: Fortis, Sotirios P, et al.
Publicado: (2015)

Novel intracellular function of IL-1 receptor antagonist type 1 in endothelial cells
por: Gabay, C, et al.
Publicado: (2003)

Investigation of the roles of novel apoptosis-controlling genes in breast cancer
por: Williams, GT, et al.
Publicado: (2008)

IL-12 priming during initial antigen contact increases generation of effector and memory CD8 T cells by changing properties
por: Chang, J, et al.
Publicado: (2003)

The role of synovial fluid cytokines IL-6, IL-23 and IL-17 in the pathogenesis and persistence of synovial inflammation in JIA patients
por: Tzimouli, V, et al.
Publicado: (2008)

Plasma MMP1, MMP8 and MMP13 expression in breast cancer: protective role of MMP8 against lymph node metastasis
por: Decock, J, et al.
Publicado: (2008)

Effects of 14 days of prophylactic resveratrol supplementation in trained endurance runners upon the inflammatory markers TNF-a, IL1β, and IL-6 following a single bout of eccentric exercise
por: Dufour, Fanny, et al.
Publicado: (2011)

NRG1 is frequently silenced by methylation in breast cancers and is a strong candidate for the 8p tumour suppressor gene
por: Chua, Y-L, et al.
Publicado: (2008)

CD8+ T cell stimulation with pegylated recombinant human IL-10 in the patient with advanced solid tumors - a Phase I study
por: Naing, Aung, et al.
Publicado: (2015)

Predictive value of procalcitonin and IL-6 for postoperative sepsis
por: Marx, G, et al.
Publicado: (2005)

IL-2 analogues: novel agents circumventing the expansion of T regulatory cells while promoting NK cell activation during IL-2 therapy
por: Sim, Geok Choo, et al.
Publicado: (2013)

ELISpot analysis of lipopolysaccharide-stimulated leukocytes: human granulocytes selectively secrete IL-8, MIP-1beta and TNFalpha
por: Smedman, Christian, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_11ljqi0qkeur0e5pmprmouv801